Cargando…
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
BACKGROUND: The aims of this study were to explore the relationship between early reduction in psychotic symptoms and the ultimate response in patients with schizophrenia treated by atypical antipsychotics, and to determine the best time to switch or maitain the regimen. We also explore the possible...
Autores principales: | Chen, Yi-Lung, Chen, Kun-Po, Chiu, Chih-Chiang, Tai, Ming-Hong, Lung, For-Wey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278161/ https://www.ncbi.nlm.nih.gov/pubmed/30509308 http://dx.doi.org/10.1186/s12888-018-1950-1 |
Ejemplares similares
-
Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015) -
New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010) -
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005) -
New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022) -
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs
por: Kucharska-Pietura, Katarzyna, et al.
Publicado: (2012)